Brind.

FDA Action and Securities Investigation Launched into Neogen Corporation Product Recall

1 report, 1 independent Updated Mon 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Levi & Korsinsky notified investors on October 5, 2026, that they had commenced an investigation into Neogen Corporation regarding potential violations of federal securities laws. This follows FDA action concerning the recall of the Neogen Vet product HYCOAT. The product was linked to fungal contamination, which resulted in nearly 100 affected horses and at least 20 horse deaths.

From pr-inside.com

Why it matters

Some supportBrind's analysis of the reports

The investigation questions whether Neogen Corporation adequately disclosed the contamination, the resulting horse deaths, and the associated regulatory risks. The company's stock fell approximately 7.2% following the FDA action.

From pr-inside.com

Who's involved

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped